Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04445662Completed
Randomised, open-label trial (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Cotinine-verified 7-day Smoking Abstinence at 12 Weeks. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04445662.